Immune Chemokine Receptor Signatures (CD183 and CD194) in tuberculosis: Insights from immunocompetent and immunocompromised tuberculosis patients
Microbes and Infectious Diseases · 26.06.2026 · 0-0
DOI: 10.21608/mid.2026.483790.3934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbes and Infectious Diseases, online erschienen am 26.06.2026. Verfasst von Ebtisam Mohammed Gad und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gad, E. M., Abdelrahman, M. M., Shafik, N. S., Mostafa, A. T., Gouda, Z. A. E. B., Elsayed, M. Z., Ahmed, N. A. E., Hamid, M. H. A., & Mohamed, D. H. (2026). Immune Chemokine Receptor Signatures (CD183 and CD194) in tuberculosis: Insights from immunocompetent and immunocompromised tuberculosis patients. Microbes and Infectious Diseases, 0(0), 0-0. https://doi.org/10.21608/mid.2026.483790.3934
Vancouver
Gad EM, Abdelrahman MM, Shafik NS, Mostafa AT, Gouda ZAEB, Elsayed MZ, et al. Immune Chemokine Receptor Signatures (CD183 and CD194) in tuberculosis: Insights from immunocompetent and immunocompromised tuberculosis patients. Microbes and Infectious Diseases. 2026;0(0):0-0. doi:10.21608/mid.2026.483790.3934
BibTeX
@article{Gad2026,
author = {Gad, Ebtisam Mohammed and Abdelrahman, mona mohamed and Shafik, Noha Saber and Mostafa, Asmaa Tarazan and Gouda, Zeinab Abu El Baha and Elsayed, Marwa Zanaty and Ahmed, Nagwa Abd El-Sadek and Hamid, Marwa Helmy Abdel and Mohamed, Dina Hamada},
title = {Immune Chemokine Receptor Signatures (CD183 and CD194) in tuberculosis: Insights from immunocompetent and immunocompromised tuberculosis patients},
journal = {Microbes and Infectious Diseases},
year = {2026},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.21608/mid.2026.483790.3934}
}
EUVIMED